Home | Health News | Themes | Search | Blog | Testimonials | Blood Bank | About Us
 
   
   
   
   
   
   
   
 
testing

 
   
REVOCON 
 



Indication & Dosage
 
 
Oral
CHOREA, BALLISM AND OTHER HYPERKINETIC MOVEMENT DISORDERS
Adult: Initially 12.5 mg bid, increased gradually to 12.5-25 mg tid. Max: 200mg daily. If no improvement at max dose for 7 days, drug unlikely to be of benefit.
Elderly: Initially 12.5 mg daily, increased gradually.
 
Oral
MODERATE TO SEVERE TARDIVE DYSKINESIA
Adult: Initially 12.5 mg daily increased gradually according to response.
   
Precautions May exacerbate symptoms of parkinsonism. Caution to be exercised when driving or performing skilled tasks. Pregnancy.
   
Potentially Life-threatening 
Adverse Drug Reactions
Drowsiness, extrapyramidal symptoms, parkinsonism, depression, orthostatic hypotension, GI disturbances.
   
Adverse Drug Reactions Neuroleptic malignant syndrome (NMS).
   
Interactions Tetrabenazine should not be given with or within 14 days of discontinuation of MAOI therapy. Blocks action of reserpine. Decreases effects of levodopa and worsen parkinsonism. Increased risk of extrapyramidal side effects when given with amantadine, metoclopramide, antipsychotics.
   
   
 

 

SocialTwist Tell-a-Friend
 
 
Home  |   Privacy Policy   |   News Lettter   |   Site Map   |  Disclaimer  |  About Us
   copyright@totalhealthneeds.com   Webmaster:- o3sa.co.in